NRG4 Antibody Blocking Peptide

NRG4 Antibody Blocking Peptide

€363.00
In stock
SKU
AC-BP6225a
Catalog Number: AC-BP6225a
Size: 500 µg
Datasheet
Request Information
Background:
The nuclear protein p100 is a proliferation-associated protein whose expression is restricted to cell cycle phases S, G2, and M. Exclusively expressed in proliferating cells from the transition G1/S until the end of cytokinesis. During mitosis it is strictly associated with the spindle pole and with the mitotic spindle, whereas during S and G2, it is diffusely distributed throughout the nucleus. The full-length cDNA encodes a 747-amino acid protein with a putative ATP/GTP-binding site motif. RT-PCR analysis demonstrated strong expression of in lung carcinoma cell lines but not in normal lung tissues. Expression was also found in adult placenta, skeletal muscle, thymus, testis, and small intestine and in fetal brain, liver, and kidney. P100 is also correlated to cancer prognosis.

Other Names:
Pro-neuregulin-4, membrane-bound isoform, Pro-NRG4, Neuregulin-4, NRG-4, NRG4

Target/Specificity:
The synthetic peptide sequences used to generate the antibody AP6225a was selected from the center and C-terminal region of human NRG4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: NRG4

Gene ID: 145957
Primary Accession: Q8WWG1
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:NRG4 Antibody Blocking Peptide